For Belgium
Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products via adr@afmps.be or via www.notifieruneffetindesirable.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.
For Grand-Duchy of Luxembourg
Please report adverse events to the Centre Régional de Pharmacovigilance de Nancy or Division de la pharmacie et des médicaments de la Direction de la santé via www.guichet.lu/pharmacovigilance or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.
